Bristol-Myers Squibb, a major pharmaceutical company, is implementing Anthropic's Claude across its 30,000 employees for various functions including drug discovery and operational tasks. This partnership positions Claude as a central tool for integrating Bristol-Myers's data sources with AI capabilities. The move signifies a broader trend of AI agents moving from pilot phases into critical pharmaceutical workflows, with implications for drug development pipelines. AI
影响 Demonstrates AI agents moving into core pharmaceutical workflows, potentially accelerating drug development and operational efficiency.
排序理由 Major enterprise adoption of a frontier AI model for core business functions. [lever_c_demoted from significant: ic=1 ai=0.7]
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
